We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current LENZ market cap is 693.57M. The company's latest EPS is USD -4.5326 and P/E is -5.58.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -58.16M | -25.03M | -25.56M | -16.09M | -14.35M |
| Net Income | -55.31M | -22.49M | -22.92M | -16.65M | -10.25M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 |
| Operating Income | -60.44M | -105.64M | -135.19M |
| Net Income | -70.76M | -101.05M | -124.65M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Assets | 287.04M | 266.23M | 188.46M | 217.32M | 202.64M |
| Total Liabilities | 62.9M | 62.21M | 4.87M | 19.16M | 9.72M |
| Total Equity | 224.15M | 204.02M | 183.58M | 198.17M | 192.92M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 401.99M | 321.9M | 188.46M |
| Total Liabilities | 17.94M | 25.61M | 4.87M |
| Total Equity | 384.05M | 296.29M | 183.58M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Operating | -34.73M | -44.13M | -90.01M | -23.94M | -39.73M |
| Investing | 115.39M | 179.26M | 226.35M | 18M | -80.39M |
| Financing | 116k | 124k | 190k | 171.27M | 169.13M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Operating | -52.85M | -87.98M | -90.01M |
| Investing | -5.74M | -241.86M | 226.35M |
| Financing | 417.47M | 597k | 190k |
| Market Cap | 693.57M |
| Price to Earnings Ratio | -5.58 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 3.78 |
| Price to Book Ratio | 3.79 |
| Dividend Yield | - |
| Shares Outstanding | 27.5M |
| Average Volume (1 week) | 96.11k |
| Average Volume (1 Month) | 112.51k |
| 52 Week Change | 57.82% |
| 52 Week High | 38.93 |
| 52 Week Low | 14.42 |
| Spread (Intraday) | 3.2 (11.43%) |
| Company Name | LENZ Therapeutics Inc |
| Address |
1201 north market st wilmington, delaware 19801 |
| Website | https://www.lenz-tx.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
